Ana Malvar

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

Richard Furie, Brad H. Rovin, Frédéric Houssiau et al. · New England Journal of Medicine · 2020 · 903 citations · Full text

B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial

Richard Furie, Gustavo Aroca, Matthew D. Cascino et al. · Annals of the Rheumatic Diseases · 2022 · 392 citations · Full text

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Jürgen Floege, Sean Barbour, Daniel Cattran et al. · Kidney International · 2019 · 257 citations · Full text

Histologic versus clinical remission in proliferative lupus nephritis

Ana Malvar, Paola Pirruccio, Valeria Albertón et al. · Nephrology Dialysis Transplantation · 2015 · 239 citations · Full text

A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis

Brad H. Rovin, Richard Furie, Y K Onno Teng et al. · Kidney International · 2021 · 184 citations · Full text